文献速递冠心病瓣膜病与结构性心脏病

阿片类药物使用障碍对心脏手术后结局和再入院的影响

Impact of opioid use disorders on outcomes and readmission following cardiac operations.
PubMed 文献 · Heart · 2020-10-29

基于2010-16年全国再入院数据库,分析冠脉搭桥和瓣膜手术患者中阿片类药物使用障碍(OUD)的患病率趋势及对结局的影响。OUD患病率从0.15%升至0.53%,增加三倍;OUD与30天再入院率升高相关(19.0% vs 13.2%),但调整后死亡率降低(1.5% vs 2.7%)。

要点

  • 心脏手术患者中OUD患病率十年间增加三倍(0.15%至0.53%)。
  • OUD患者30天再入院率更高(19.0% vs 13.2%),血栓栓塞和感染事件增加。
  • 调整后OUD与住院死亡率降低相关(1.5% vs 2.7%),但住院时间更长。

核心结论

  • OUD在心脏手术患者中患病率急剧上升,虽不增加住院死亡率,但可预测30天再入院。

研究设计与样本

  • 回顾性队列研究,使用2010-16年全国再入院数据库,纳入冠脉搭桥和瓣膜手术患者(排除感染性心内膜炎),估计1 978 276例,其中5707例(0.3%)有OUD。

主要发现

  • OUD患病率从2010年0.15%升至2016年0.53%(趋势P<0.001)。
  • OUD患者更年轻(54.0 vs 66.0岁,p<0.001),医疗补助保险比例更高(28.2% vs 6.2%,p<0.001),最低收入四分位比例更高(33.6% vs 27.1%,p<0.001)。
  • 多变量调整后,OUD与死亡率降低相关(1.5% vs 2.7%,p=0.001),总体并发症率相似(36.1% vs 35.1%,p=0.363),但血栓栓塞事件(1.3% vs 0.8%,p<0.001)和感染事件(4.1% vs 2.8%,p<0.001)增加。
  • OUD患者30天再入院率更高(19.0% vs 13.2%,p<0.001),住院时间更长(11.4 vs 10.3天,p<0.001),住院费用相似($50 766 vs $50 759,p=0.994)。

临床怎么用

  • 对心脏手术OUD患者应加强出院前干预和护理协调,以改善结局并降低再入院风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: While opioid use disorder (OUD) has been previously associated with increased morbidity and resource use in cardiac operations, its impact on readmissions is understudied. METHODS: Patients undergoing coronary artery bypass grafting and valve repair or replacement, excluding infective endocarditis, were identified in the 2010-16 Nationwide Readmissions Database. Using International Classification of Diseases 9/10, we tabulated OUD and other characteristics. Multivariable regression was used to adjust for differences. RESULTS: Of an estimated 1 978 276 patients who had cardiac surgery, 5707 (0.3%) had OUD. During the study period, the prevalence of OUD increased threefold (0.15% in 2010 vs 0.53% in 2016, parametric trend<0.001). Patients with OUD were more likely to be younger (54.0 vs 66.0 years, p<0.001), insured by Medicaid (28.2 vs 6.2%, p<0.001) and of the lowest income quartile (33.6 vs 27.1%, p<0.001). After multivariable adjustment, OUD was associated with decreased mortality (1.5 vs 2.7%, p=0.001). Although these patients had similar rates of overall complications (36.1 vs 35.1%, p=0.363), they had increased thromboembolic (1.3 vs 0.8%, p<0.001) and infectious (4.1 vs 2.8%, p<0.001) events, as well as readmission at 30 days (19.0 vs 13.2%, p<0.001). While patients with OUD had similar hospitalisation costs ($50 766 vs $50 759, p=0.994), they did have longer hospitalisations (11.4 vs 10.3 days, p<0.001). CONCLUSION: The prevalence of OUD among cardiac surgical patients has steeply increased over the past decade. Although the presence of OUD was not associated with excess mortality at index hospitalisation, it was predictive of 30-day readmission. Increased attention to predischarge interventions and care coordination may improve outcomes in this population.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Madrigal J, Sanaiha Y, Hadaya J, et al. Impact of opioid use disorders on outcomes and readmission following cardiac operations. Heart. 2020. PMID: 33122299. doi:10.1136/heartjnl-2020-317618

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。